Closed
0.5 4.17
24h
Min
0.47
Max
0.5
Income | -147M -192M |
---|---|
Sales | -23K 11K |
EPS | -0.172 |
Profit margin | -1,744,863.636 |
Employees | 300 |
EBITDA | -12M -58M |
Recommendations | Sell |
---|---|
12 Months Forecast | +108.33% upside |
Next Earnings | 5 maj 2025 |
---|
Market Cap | -57M 159M |
---|---|
Previous open | -3.67 |
Previous close | 0.5 |
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 1 USD 108.33%
High 1 USD
Low 1 USD
Based on 2 Wall Street analysts offering 12 month price targets forLyell Immunopharma Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$